durvalumab
astrazeneca
['durvalumab', 'bladder']
#cctg @ #asco22 #asco2022 cctg bl.13
a randomized phase ii trial assessing trimodality therapy with or without adjuvant durvalumab to treat patients with muscle-invasive bladder cancer (nct03768570)
abstract link: 
The Canadian Cancer Trials Group is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies.